Literature DB >> 12873692

The design and testing of novel clinical parameters for dose comparison.

Nathan L Childress1, Isaac I Rosen.   

Abstract

PURPOSE: New multidimensional dose comparison parameters, normalized agreement test (NAT) values and the NAT index, are introduced and compared with an ideal dose comparison parameter. In this article, we analyze a clinically based two-dimensional (2D) quantitative dose comparison case using a wide range of new and old comparison tools. In doing so, we address the benefits and limitations of many common dose comparison tools. METHODS AND MATERIALS: An in-house software program was developed using the MATLAB 6.5 programming language. Using this software, several 2D quantitative dose comparison parameters were calculated for the computed and measured dose distributions in an intensity-modulated radiotherapy (IMRT) prostate cancer treatment. The experiences gained in the design and testing of this software program form the basis of the dose comparison tool analysis.
RESULTS: Each dose comparison tool has unique strengths and weaknesses. The underlying assumptions of the NAT values and NAT index lead to acceptable generalized behavior, but are not always valid.
CONCLUSION: A thorough 2D quantitative dose comparison analysis can only be accomplished through the use of many dose comparison tools. The introduction of the NAT index allows a 2D dose comparison to be reduced to a single value, and is thus ideal for setting clinical acceptance criteria for IMRT verifications.

Entities:  

Mesh:

Year:  2003        PMID: 12873692     DOI: 10.1016/s0360-3016(03)00430-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Toward a better understanding of the gamma index: Investigation of parameters with a surface-based distance method.

Authors:  Heng Li; Lei Dong; Lifei Zhang; James N Yang; Michael T Gillin; X Ronald Zhu
Journal:  Med Phys       Date:  2011-12       Impact factor: 4.071

2.  Three-dimensional gamma analysis of dose distributions in individual structures for IMRT dose verification.

Authors:  Yuuki Tomiyama; Fujio Araki; Takeshi Oono; Kazunari Hioki
Journal:  Radiol Phys Technol       Date:  2014-05-06

3.  Benchmark measurements and simulations of dose perturbations due to metallic spheres in proton beams.

Authors:  Wayne D Newhauser; Laura Rechner; Dragan Mirkovic; Pablo Yepes; Nicholas C Koch; Uwe Titt; Jonas D Fontenot; Rui Zhang
Journal:  Radiat Meas       Date:  2013-11-01       Impact factor: 1.898

4.  Dose calculation with respiration-averaged CT processed from cine CT without a respiratory surrogate.

Authors:  Adam C Riegel; Moiz Ahmad; Xiaojun Sun; Tinsu Pan
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

5.  Dose distribution verifications of IMRT for NPC.

Authors:  Qin Li; Liang Li; Jun Han; Zhiwen Liang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

6.  Breaking bad IMRT QA practice.

Authors:  Strahinja Stojadinovic; Luo Ouyang; Xuejun Gu; Arnold Pompoš; Qinan Bao; Timothy D Solberg
Journal:  J Appl Clin Med Phys       Date:  2015-05-08       Impact factor: 2.102

7.  Analysis of dose comparison techniques for patient-specific quality assurance in radiation therapy.

Authors:  Liting Yu; Timothy L S Tang; Naasiha Cassim; Alexander Livingstone; Darren Cassidy; Tanya Kairn; Scott B Crowe
Journal:  J Appl Clin Med Phys       Date:  2019-10-15       Impact factor: 2.102

8.  Visualization Method for the Cell-Level Vesicle Transport Using Optical Flow and a Diverging Colormap.

Authors:  Seohyun Lee; Hyuno Kim; Hideo Higuchi; Masatoshi Ishikawa
Journal:  Sensors (Basel)       Date:  2021-01-13       Impact factor: 3.576

9.  Dose perturbations from implanted helical gold markers in proton therapy of prostate cancer.

Authors:  Annelise Giebeler; Jonas Fontenot; Peter Balter; George Ciangaru; Ronald Zhu; Wayne Newhauser
Journal:  J Appl Clin Med Phys       Date:  2009-01-27       Impact factor: 2.102

10.  To propose adding index of achievement (IOA) to IMRT QA process.

Authors:  Dong-Su Kim; Siyong Kim; Seong-Hee Kang; Tae-Ho Kim; So-Hyun Park; Kyeong-Hyeon Kim; Min-Seok Cho; Dong-Seok Shin; Yu-Yun Noh; Jin-Beom Chung; Tae Suk Suh
Journal:  Radiat Oncol       Date:  2018-06-15       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.